Chris Diorio - Jun 10, 2024 Form 4 Insider Report for IMPINJ INC (PI)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Yukio Morikubo, Attorney in fact for Chris Diorio
Stock symbol
PI
Transactions as of
Jun 10, 2024
Transactions value $
-$1,247,303
Form type
4
Date filed
6/11/2024, 06:56 PM
Previous filing
Jun 4, 2024
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PI Common Stock Options Exercise $112K +5K +1.75% $22.40 291K Jun 10, 2024 Direct
transaction PI Common Stock Sale -$393K -2.67K -0.92% $147.36 289K Jun 10, 2024 Direct F1, F2
transaction PI Common Stock Sale -$329K -2.22K -0.77% $148.18 286K Jun 10, 2024 Direct F1, F3
transaction PI Common Stock Sale -$16.7K -112 -0.04% $149.36 286K Jun 10, 2024 Direct F1, F4
transaction PI Common Stock Options Exercise $112K +5K +1.75% $22.40 291K Jun 11, 2024 Direct
transaction PI Common Stock Sale -$309K -2.12K -0.73% $145.89 289K Jun 11, 2024 Direct F1, F5
transaction PI Common Stock Sale -$423K -2.88K -1% $146.94 286K Jun 11, 2024 Direct F1, F6
transaction PI Common Stock Sale -$590 -4 0% $147.45 286K Jun 11, 2024 Direct F1
holding PI Common Stock 552K Jun 10, 2024 by DFT L.L.C.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PI Stock Option (right to buy) Options Exercise $0 -5K -4.15% $0.00 116K Jun 10, 2024 Common Stock 5K $22.40 Direct F7
transaction PI Stock Option (right to buy) Options Exercise $0 -5K -4.33% $0.00 111K Jun 11, 2024 Common Stock 5K $22.40 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024.
F2 The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $146.915 to $147.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3 The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $147.925 to $148.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F4 The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $149.27 to $149.41 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F5 The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $145.29 to $146.2625, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F6 The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $146.33 to $147.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F7 The option became fully vested on June 11, 2022.